Relay Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
RLAY on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
399 Binney Street, 2 Nd Floor, Cambridge, MA

Insiders trading volume in the past year

Relay Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanjiv Patel President and CEO, Director $10.1M -$1.29M -11.3% Dec 16, 2024
Donald A. Bergstrom President, R&D $3.16M -$114K -3.49% Oct 28, 2024
Peter Rahmer Chief Corporate Development Officer $2.36M -$938K -28.4% Oct 28, 2024
Brian Adams Chief Legal Officer $1.95M -$63.5K -3.15% Oct 28, 2024
Thomas Catinazzo Chief Financial Officer $1.81M -$290K -13.8% Oct 28, 2024
Jami Rubin Director $339K Jun 10, 2024
Andy Porter Chief Administrative Officer $272K Oct 28, 2022
Sekar Kathiresan Director Jun 3, 2024
Douglas S. Ingram Director Jun 3, 2024
Linda A. Hill Director Jun 3, 2024
Mark Murcko Director Jun 3, 2024
Alexis Borisy Director Jun 3, 2024
Laura Shawver Director Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for Relay Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.